The Wayback Machine - http://web.archive.org/web/20240211152505/https://finance.yahoo.com/sectors/healthcare/
Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
6.611T
Market Weight
11.60%
Industries
11
Companies
1216
Healthcare S&P 500 ^GSPC
Loading Chart for Healthcare
(right-click to deleteright-click to manage)(long-press to drag)(drag to change anchor time)

Day Return

Sector
0.01%
S&P 500
0.57%

YTD Return

Sector
4.43%
S&P 500
5.38%

1-Year Return

Sector
5.61%
S&P 500
22.07%

3-Year Return

Sector
7.85%
S&P 500
28.37%

5-Year Return

Sector
65.79%
S&P 500
85.50%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

IndustryMarket WeightDay ReturnYTD Return
All Industries 100% 0.01% 4.43%
Drug Manufacturers - General 33.99% -0.06% 9.92%
Healthcare Plans 13.69% 0.07% -0.36%
Medical Devices 12.79% -0.61% 5.11%
Biotechnology 11.51% 0.85% -2.01%
Diagnostics & Research 11.03% -0.52% 0.77%
Medical Instruments & Supplies 6.69% -0.01% 5.57%
Drug Manufacturers - Specialty & Generic 2.94% 0.91% 2.55%
Medical Care Facilities 2.75% 0.33% 6.09%
Medical Distribution 2.29% 0.79% 6.82%
Health Information Services 2.02% 0.45% 4.05%
Pharmaceutical Retailers 0.29% -1.57% -14.91%

All Industries

Note: Percentage % data on heatmap indicates Day Return

Largest Companies in This Sector

Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
740.16 730.41 10.70% 702.639B +0.61% +26.97%
Buy
518.22 599.98 7.33% 481.044B -0.36% -1.57%
Buy
156.76 175.05 5.75% 377.365B +0.23% +0.01%
Buy
125.45 133.18 4.89% 320.832B -0.92% +15.07%
Buy
174.08 176.50 4.70% 308.599B -0.41% +12.33%
Buy
550.75 593.24 3.24% 212.849B -0.03% +3.76%
Buy
111.81 125.37 2.97% 195.186B -0.55% +1.58%
Buy
242.95 260.20 2.77% 181.747B -1.19% +5.02%
Buy
291.12 305.41 2.37% 155.749B -1.27% +1.08%
Buy
27.56 32.14 2.37% 155.672B -0.04% -4.27%
Buy

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

Name
Last Price
Net Assets
Expense Ratio
YTD Return
144.01 39.294B 0.09% +5.59%
263.45 19.913B 0.10% +5.09%
134.59 7.338B 0.45% -0.93%
91.04 6.624B 0.35% +1.96%
56.72 5.449B 0.40% +5.10%

Mutual Fund Opportunities

Name
Last Price
Net Assets
Expense Ratio
YTD Return
215.22 46.292B 0.34% +2.92%
90.75 46.292B 0.34% +2.93%
131.85 19.913B 0.10% +5.13%
93.10 14.847B 0.80% +5.92%
93.34 14.712B 0.80% +5.92%

Healthcare Research

Discover the Latest Analyst and Technical Research for This Sector

  • Analyst Report: ICON Public Limited Company

    Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

    Rating
    Bearish
    Price Target
     
  • Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

    In this edition, we say viva Veeva; the China housing market is building up to something positive; computer software has a great future; and Sensata, Sunny Optical, and Onsemi.

     
  • Analyst Report: AptarGroup, Inc.

    Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

    Rating
    Neutral
    Price Target
     
  • Analyst Report: IDEXX Laboratories, Inc.

    Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

    Rating
    Bearish
    Price Target
     

From the Community

Healthcare News